Teladoc Health Inc (NYSE:TDOC) is plunging today after the virtual healthcare provider reported second-quarter revenue of $606.9 million, missing Wall Street's estimate of $615.4 million, and lowered its full-year revenue guidance.
Teladoc Health NYSE: TDOC reported second-quarter results within its consolidated guidance range, supported by stronger-than-expected profitability in its Integrated Care segment, while lower cash-pay revenue at BetterHelp prompted the company to reduce its full-year revenue outlook.
Teladoc Health, Inc. (TDOC) Q2 2026 Earnings Call Transcript
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Teladoc (TDOC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to a loss of $0.19 per share a year ago.
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Teladoc (TDOC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2026.
The latest trading day saw Teladoc (TDOC) settling at $9.65, representing a +2.33% change from its previous close.
Teladoc (TDOC) closed the most recent trading day at $9.21, moving +1.54% from the previous trading session.
The latest trading day saw Teladoc (TDOC) settling at $8.48, representing a -2.42% change from its previous close.
Teladoc (TDOC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Teladoc (TDOC) concluded the recent trading session at $7.81, signifying a +1.56% move from its prior day's close.
Teladoc (TDOC) reached $7.57 at the closing of the latest trading day, reflecting a +1.47% change compared to its last close.